Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

15 Oct 2019

Faster, more agile vaccine tech needed to fight tomorrow’s epidemics

Read more

Read article

15 Oct 2019

CEPI launches new call for innovative platform technologies to rapidly respond to Disease X
New call for proposals invites applications for platform technologies to quickly develop vaccines and immunoprophylactics against Disease X

Read more

18 Sep 2019

A World at Risk: Global Preparedness Monitoring Board launches first annual report
The report, based off of evidence from seven review papers that explore the challenge of outbreak preparedness, outlines the growing threat and potential devastation of infectious disease epidemics, alongside the urgent need for investment.

Read more

02 Sep 2019

Disease Outbreak Update: Ebola returns to Uganda
ProMED reports on the death of a 9-year-old girl in Uganda and the death count now exceeding 2000.

Read more

21 Aug 2019

CEPI and Africa CDC to host panel event at TICAD 7
Event will explore how epidemic preparedness and response in Africa can be strengthened

Read more

12 Aug 2019

CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate
Public Health Vaccine, LLC. will partner with Crozet BioPharma to develop the Nipah vaccine candidate. Up to $9 million of this funding will go to Ology Bioservices, Inc., to support manufacturing and stockpiling of the vaccine.

Read more

12 Aug 2019

Strengthening epidemic preparedness and response in Africa
Find out about Africa CDC's and CEPI's official side event at TICAD 7 on August 28, 2019

Read more

25 Jul 2019

CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine

Read more

Read article

17 Jul 2019

CEPI awards funding agreement worth up to US$9.5 million to Colorado State University to develop a human vaccine against Rift Valley fever

Read more

10 Jul 2019

How CEPI is preparing to combat Rift Valley fever
Outbreaks of Rift Valley fever virus usually occur in animals but are now increasing in frequency among humans with recent outbreaks in South Africa, Kenya, and Mayotte. CEPI is working to combat this virus before the threat of a larger epidemic becomes reality. 

Read more

10 Jul 2019

CEPI awards contract worth up to US$12.5 million to consortium led by Wageningen Bioveterinary Research to develop a human vaccine against Rift Valley fever
With support from the EU’s Horizon 2020 programme, CEPI will provide funding for vaccine manufacturing, preclinical research, and a phase 1 study to assess a single-dose vaccine candidate.

Read more

©2019 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.